Filing Flows › Camp4 Therapeutics (CAMP) › Q2 2026 › vs Q2 2025
Camp4 Therapeutics (CAMP) Q2 2026 vs Q2 2025 (year over year)
Camp4 Therapeutics's revenue rose $282K (+19%) from $1.5M in Q2 2025 to $1.8M in Q2 2026.
Camp4 Therapeutics, Q2 2026: revenue $1.8M (+19% year over year), operating margin -752.1%, net loss $33.5M, operating cash flow −$12.7M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $1.5M | $282K | +19% |
| Net loss | $33.5M | $12.6M | $20.9M | +166% |
| Costs & expenses | $35.3M | $14.5M | $20.8M | +143% |
| Operating costs | $15.2M | $14.5M | $634K | +4% |
| Interest & other, net | $20.1M | −$441K | $20.6M | — |
| Research & development | $10.8M | $10.3M | $474K | +5% |
| General & admin | $4.3M | $4.2M | $160K | +4% |
| Operating cash sources | $33.5M | $12.6M | $20.9M | +166% |
| Depreciation & amortization | $515K | $430K | $85K | +20% |
| Share-based compensation | $1.9M | $1.0M | $929K | +93% |
| Working capital & other | $18.4M | $812K | $17.6M | 23× |
| Cash used in operations | $12.7M | $10.3M | $2.3M | +23% |
| Net loss absorbed | $33.5M | $12.6M | $20.9M | +166% |
Questions
How much did Camp4 Therapeutics's revenue grow year over year in Q2 2026?
Camp4 Therapeutics's revenue rose $282K (+19%) from $1.5M in Q2 2025 to $1.8M in Q2 2026.